Key Insights
The North America pharmaceutical plastic packaging market is a significant sector experiencing robust growth, projected to reach a substantial size. The market's 5.97% CAGR from 2019 to 2024, coupled with continued industry expansion, suggests a sizable market value exceeding $16.51 billion by 2025. This growth is fueled by several key factors. The increasing demand for pharmaceuticals, driven by an aging population and rising prevalence of chronic diseases, necessitates efficient and safe packaging solutions. Furthermore, advancements in plastic packaging technology, such as the development of tamper-evident and child-resistant packaging, are enhancing product security and patient safety, further boosting market demand. Stringent regulatory requirements regarding drug safety and packaging standards also contribute to the market's expansion, pushing manufacturers to adopt advanced and compliant packaging materials. The preference for convenient and user-friendly packaging formats, like blister packs and unit-dose containers, also fuels growth.
However, the market faces challenges. Concerns regarding the environmental impact of plastic waste and the increasing adoption of sustainable packaging alternatives, such as biodegradable plastics and paper-based packaging, represent significant restraints. Fluctuations in raw material prices and the complexities associated with regulatory compliance also impact market dynamics. Despite these challenges, the market's expansion is anticipated to continue, driven by strong pharmaceutical production and innovative packaging solutions that address both consumer and environmental concerns. Key players in the North American market, including Gerresheimer AG, Amcor, and Berry Global, are actively investing in research and development to innovate and meet evolving market demands, contributing to the sector's continued growth trajectory.

North America Pharmaceutical Plastic Packaging Market Report: 2019-2033
This comprehensive report provides a detailed analysis of the North America pharmaceutical plastic packaging market, encompassing market dynamics, growth trends, regional segmentation, product landscape, key players, and future outlook. The study period covers 2019-2033, with a base year of 2025 and a forecast period of 2025-2033. The report offers invaluable insights for industry professionals, investors, and stakeholders seeking to understand and capitalize on opportunities within this dynamic market. The market is segmented by packaging type (e.g., blister packs, bottles, vials, tubes), material (e.g., HDPE, PP, PET), and application (e.g., solid dosage forms, liquid dosage forms). The total market size is projected at xx Million units in 2025.
North America Pharmaceutical Plastic Packaging Market Dynamics & Structure
The North American pharmaceutical plastic packaging market is characterized by a moderately concentrated structure, with several large multinational companies holding significant market share. The market is driven by technological advancements, stringent regulatory frameworks, and growing demand for sustainable and innovative packaging solutions. The increasing prevalence of chronic diseases and the rising adoption of pharmaceutical products are key factors fueling market growth. Competition from alternative packaging materials and fluctuating raw material prices pose challenges.
- Market Concentration: The top 5 players hold an estimated xx% market share in 2025.
- Technological Innovation: Focus on lightweighting, recyclability, and improved barrier properties is driving innovation.
- Regulatory Landscape: Stringent regulations regarding drug safety and environmental concerns impact packaging choices.
- Competitive Substitutes: Glass and other materials present competitive alternatives, although plastic maintains dominance.
- End-User Demographics: The aging population and increasing prevalence of chronic diseases contribute to market growth.
- M&A Trends: Consolidation activity is expected to continue, driven by economies of scale and geographic expansion. An estimated xx M&A deals occurred between 2019 and 2024.
North America Pharmaceutical Plastic Packaging Market Growth Trends & Insights
The North American pharmaceutical plastic packaging market exhibits a robust growth trajectory, driven by factors such as the increasing demand for pharmaceutical products, the growing adoption of innovative packaging technologies, and favorable government regulations. The market size is projected to expand at a CAGR of xx% during the forecast period (2025-2033), reaching xx Million units by 2033. This growth is attributed to several factors, including the rising prevalence of chronic diseases, increasing healthcare expenditure, and the growing adoption of convenient and tamper-evident packaging solutions. The market penetration rate for sustainable packaging is gradually increasing, driven by consumer preferences and environmental concerns. Technological disruptions such as the introduction of smart packaging solutions and improved recycling technologies are further shaping market growth. Consumer behavior is shifting towards eco-friendly and convenient options, influencing packaging choices.

Dominant Regions, Countries, or Segments in North America Pharmaceutical Plastic Packaging Market
The United States dominates the North American pharmaceutical plastic packaging market, accounting for the largest market share in 2025 (xx%). This dominance is fueled by several factors:
- Large Pharmaceutical Industry: The US has a robust pharmaceutical industry with significant production and consumption of drugs.
- High Healthcare Expenditure: High healthcare spending translates to increased demand for pharmaceutical packaging.
- Advanced Infrastructure: Well-developed infrastructure facilitates efficient production and distribution of packaged pharmaceuticals.
- Strong Regulatory Framework: Stringent regulations drive innovation and adoption of advanced packaging technologies.
- Growing Adoption of Innovative Packaging: Consumers prefer convenient and tamper-evident packaging solutions.
Canada and Mexico are also important markets, exhibiting moderate growth rates.
North America Pharmaceutical Plastic Packaging Market Product Landscape
The market features a wide range of products including blister packs, bottles, vials, tubes, and closures made from various materials such as HDPE, PP, PET, and PVC. Innovation focuses on improving barrier properties, enhancing convenience, and incorporating sustainability features like recyclability and reduced environmental impact. Many packaging solutions now emphasize tamper-evidence and child-resistance features, complying with stringent regulatory requirements. Technological advancements such as smart packaging, incorporating features like track and trace capabilities, are gaining traction.
Key Drivers, Barriers & Challenges in North America Pharmaceutical Plastic Packaging Market
Key Drivers:
- Increasing demand for pharmaceutical products due to rising prevalence of chronic diseases.
- Growing adoption of innovative packaging technologies, such as lightweighting and recyclability.
- Stringent government regulations promoting sustainable packaging practices.
Key Barriers & Challenges:
- Fluctuations in raw material prices, particularly for polymers.
- Intense competition from alternative packaging materials.
- Regulatory hurdles and compliance costs associated with safety and environmental standards. This represents an estimated xx% increase in production costs in 2025.
- Supply chain disruptions impacting material availability and timely delivery.
Emerging Opportunities in North America Pharmaceutical Plastic Packaging Market
- Growing demand for sustainable and eco-friendly packaging solutions.
- Increasing adoption of smart packaging technologies with integrated features.
- Expansion into niche applications, such as personalized medicine and drug delivery systems.
- Development of innovative packaging formats improving product protection and usability.
Growth Accelerators in the North America Pharmaceutical Plastic Packaging Market Industry
Strategic partnerships between packaging manufacturers and pharmaceutical companies are driving innovation and market expansion. Technological breakthroughs, particularly in materials science and packaging design, are creating more sustainable, efficient, and cost-effective solutions. The expanding market for personalized medicine presents significant growth opportunities for specialized pharmaceutical packaging.
Key Players Shaping the North America Pharmaceutical Plastic Packaging Market Market
- Gerresheimer AG
- Amcor Group GmbH
- Berry Global Group Inc
- Comar LLC
- Klockner Pentaplast Group
- Nipro Medical Corporation
- James Alexander Corporation
- Drug Plastics Group
- Pretium Packaging
- Bormioli Pharma United States Inc (Bormioli Pharma S p A )
- Silgan Plastics (Silgan Holdings Inc)
- List Not Exhaustive
Notable Milestones in North America Pharmaceutical Plastic Packaging Market Sector
- July 2024: Amcor Group GmbH achieved nine months of recognition for its AmSky™ and AmPrima™ packaging solutions, gaining a spot on Walmart’s Circular Connector platform. This highlights growing acceptance of sustainable packaging in the market.
- April 2024: Berry Global Group, Inc. celebrated six months since launching a lightweight tube closure solution, made from recycled plastics, significantly reducing greenhouse gas emissions. This demonstrates a shift towards eco-friendly materials.
In-Depth North America Pharmaceutical Plastic Packaging Market Market Outlook
The North American pharmaceutical plastic packaging market is poised for continued growth, driven by technological advancements, regulatory changes, and evolving consumer preferences. Opportunities abound in sustainable packaging, smart packaging, and specialized applications. Strategic partnerships and investments in research and development will be crucial for companies to maintain a competitive edge and capitalize on the market's long-term potential. The focus on sustainability and improved recyclability will continue to shape the market landscape, presenting significant opportunities for companies that can offer innovative and environmentally responsible solutions.
North America Pharmaceutical Plastic Packaging Market Segmentation
-
1. Raw Material
- 1.1. Polypropylene (PP)
- 1.2. Polyethylene Terephthalate (PET)
- 1.3. Low Density Polyethylene (LDPE)
- 1.4. High Density Polyethylene (HDPE)
- 1.5. Other Raw Materials
-
2. Product Type**
- 2.1. Solid Containers
- 2.2. Dropper Bottles
- 2.3. Nasal Spray Bottles
- 2.4. Liquid Bottles
- 2.5. Oral Care
- 2.6. Pouches
- 2.7. Vials and Ampoules
- 2.8. Cartridges
- 2.9. Syringes
- 2.10. Caps and Closure
- 2.11. Other Product Types
North America Pharmaceutical Plastic Packaging Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico

North America Pharmaceutical Plastic Packaging Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.97% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.3. Market Restrains
- 3.3.1. Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales
- 3.4. Market Trends
- 3.4.1. Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Pharmaceutical Plastic Packaging Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 5.1.1. Polypropylene (PP)
- 5.1.2. Polyethylene Terephthalate (PET)
- 5.1.3. Low Density Polyethylene (LDPE)
- 5.1.4. High Density Polyethylene (HDPE)
- 5.1.5. Other Raw Materials
- 5.2. Market Analysis, Insights and Forecast - by Product Type**
- 5.2.1. Solid Containers
- 5.2.2. Dropper Bottles
- 5.2.3. Nasal Spray Bottles
- 5.2.4. Liquid Bottles
- 5.2.5. Oral Care
- 5.2.6. Pouches
- 5.2.7. Vials and Ampoules
- 5.2.8. Cartridges
- 5.2.9. Syringes
- 5.2.10. Caps and Closure
- 5.2.11. Other Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.1. Market Analysis, Insights and Forecast - by Raw Material
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Gerresheimer AG
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Amcor Group GmbH
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Berry Global Group Inc
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Comar LLC
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Klockner Pentaplast Group
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Nipro Medical Corporation
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 James Alexander Corporation
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Drug Plastics Group
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Pretium Packaging
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Bormioli Pharma United States Inc (Bormioli Pharma S p A )
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.1 Gerresheimer AG
List of Figures
- Figure 1: North America Pharmaceutical Plastic Packaging Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: North America Pharmaceutical Plastic Packaging Market Share (%) by Company 2024
List of Tables
- Table 1: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 4: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 5: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2019 & 2032
- Table 6: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2019 & 2032
- Table 7: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Region 2019 & 2032
- Table 9: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Raw Material 2019 & 2032
- Table 10: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Raw Material 2019 & 2032
- Table 11: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Product Type** 2019 & 2032
- Table 12: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Product Type** 2019 & 2032
- Table 13: North America Pharmaceutical Plastic Packaging Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: North America Pharmaceutical Plastic Packaging Market Volume Billion Forecast, by Country 2019 & 2032
- Table 15: United States North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: United States North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 17: Canada North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Canada North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 19: Mexico North America Pharmaceutical Plastic Packaging Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Mexico North America Pharmaceutical Plastic Packaging Market Volume (Billion) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Pharmaceutical Plastic Packaging Market?
The projected CAGR is approximately 5.97%.
2. Which companies are prominent players in the North America Pharmaceutical Plastic Packaging Market?
Key companies in the market include Gerresheimer AG, Amcor Group GmbH, Berry Global Group Inc, Comar LLC, Klockner Pentaplast Group, Nipro Medical Corporation, James Alexander Corporation, Drug Plastics Group, Pretium Packaging, Bormioli Pharma United States Inc (Bormioli Pharma S p A ), Silgan Plastics (Silgan Holdings Inc )*List Not Exhaustive.
3. What are the main segments of the North America Pharmaceutical Plastic Packaging Market?
The market segments include Raw Material, Product Type**.
4. Can you provide details about the market size?
The market size is estimated to be USD 16.51 Million as of 2022.
5. What are some drivers contributing to market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
6. What are the notable trends driving market growth?
Rising Demand for Sealed and Protective Caps and Closure for Pharmaceutical Containers.
7. Are there any restraints impacting market growth?
Demand for Child-resistant Packaging Solutions Drive the Demand for Pharmaceutical Plastic Packaging; Transitioning from Glass to Plastics Packaging Significantly Driving the Sales.
8. Can you provide examples of recent developments in the market?
July 2024: Amcor Group GmbH completed nine months of receiving recognition for its AmSky™ and AmPrima™, which helped the company earn a place on Walmart’s Circular Connector platform. AmSky is a polyvinyl chloride (PVC) and aluminum-free recycle-ready blister pack for pharmaceuticals. Disrupting the decades-long, over-the-counter standard drug pack, it uses high-density polyethylene (HDPE). AmPrima is a portfolio of recycle-ready packaging solutions for both solid and liquid content.April 2024: Berry Global Group, Inc. completed six months since the launch of a lightweight tube closure solution. This innovative closure, crafted from either virgin polyethylene (PE) and polypropylene (PP) or food-safe post-consumer recycled plastics (rPE and rPP), significantly contributes to reducing greenhouse gas emissions. It is particularly suited for personal care and pharmaceutical applications.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 4950, and USD 6800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Pharmaceutical Plastic Packaging Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Pharmaceutical Plastic Packaging Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Pharmaceutical Plastic Packaging Market?
To stay informed about further developments, trends, and reports in the North America Pharmaceutical Plastic Packaging Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence